The Biggest Shortcoming With Glide-Paths In Target-Date Funds
Ben Inker (GMO) explains how valuation should be a key driver of how an investor’s asset allocation looks at a given life stage.
Disclosure: None.
How did you like this article? Let us know so we can better customize your reading experience.
Comments
Leave a comment to automatically be entered into
our contest to win a free Echo Show.
